Medical Health Cluster


The U.S. COVID-19 Public Health Emergency Ends in May. Here’s What Will Change

Almost since the emergence of COVID-19, the U.S. has treated the disease as both a national and public health emergency. That will end on May 11, 2023, the Biden Administration announced Jan. 30. The decision to end these important designations will have wide-ranging impacts on many health measures that Americans […]

Read More

County-Level Social Vulnerability and Emergency Department Visits for Firearm Injuries

Summary What is already known about this topic? At least 100,000 persons in the United States experience a fatal or nonfatal firearm injury each year. What is added by this report? During 2018–2021, among 10 jurisdictions participating in CDC’s Firearm Injury Surveillance Through Emergency Rooms program, counties with higher overall […]

Read More

US to Extend COVID Public Health Emergency

Federal health officials will extend the COVID-19 public health emergency past mid-July, which will continue pandemic-era policies as coronavirus cases increase again. The U.S. Department of Health and Human Services has renewed the emergency order since January 2020. The declaration allows the U.S. to grant emergency authorizations of drugs, vaccines, […]

Read More

Emergency Use Authorization

About Emergency Use Authorizations (EUAs) The Emergency Use Authorization (EUA) authority allows FDA to help strengthen the nation’s public health protections against chemical, biological, radiological, and nuclear (CBRN) threats including infectious diseases, by facilitating the availability and use of medical countermeasures (MCMs) needed during public health emergencies. Under section 564 of the […]

Read More

US FDA Gives Emergency Use Approval for GSK-Vir COVID-19 Antibody Drug

The U.S. Food and Drug Administration gave an emergency use authorization to the antibody treatment developed by Vir Biotechnology (VIR.O) and GlaxoSmithKline (GSK.L) for treating mild-to-moderate COVID-19 in people aged 12 years and older. The antibody drug, Sotrovimab, is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy, the health […]

Read More